KemPharm, Inc. Announces Orange Book Listing for Six Patents Covering Serdexmethylphenidate – GlobeNewswire
KemPharm, Inc. Announces Orange Book Listing for Six Patents Covering Serdexmethylphenidate GlobeNewswire
In: PATENT NEWS
KemPharm, Inc. Announces Orange Book Listing for Six Patents Covering Serdexmethylphenidate GlobeNewswire
We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. https://www.gov.uk/government/publications/designs-hearing-decision-o37421 Content Reproduced verbatim from... Continue reading
In: PATENT NEWS
Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development Candidates Across 153 Global Jurisdictions Business Wire
In: PATENT NEWS
RedHill Biopharma Receives Allowances for US Patent Applications Covering Opaganib and RHB-107 for COVID-19 PRNewswire
In: PATENT NEWS
Can Pharmaceutical Companies Counter the Waiver of their Patents for COVID-19 Vaccines through Investment Treaty Arbitration? Lexology
In: TRADEMARK NEWS
Restaurant trademark ‘invalidated’ due to ‘satirizing’ Chinese soccer team Global Times
In: PATENT NEWS
How to obtain patent protection for strains of microorganism in Russia IAM
In: PATENT NEWS
Covid-19 Vaccine Makers Press Countries to Oppose Patent Waiver The Wall Street Journal A patent waiver on COVID vaccines is right and fair Nature.com BUSINESS: Biden backs waiving vaccine patents. Is climate tech next? E&E News Op-Ed: Protect the Patents | MedPage Today MedPage Today COVID-19 Special: To waive or not to waive vaccine... Continue reading
In: PATENT NEWS
Pivot Bio is seeking a Collaboration Management IP Counsel IPWatchdog.com
In: PATENT NEWS
Compulsory patent licences in Australia: time to take another look? – Intellectual Property – Australia Mondaq News Alerts
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION